Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma
This study has been withdrawn prior to enrollment.
Information provided by:
National Cancer Institute (NCI)
First received: June 10, 2004
Last updated: July 9, 2013
Last verified: July 2006
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Study Completion Date:||No date given|
|Primary Completion Date:||No date given|